Published Ms. Dhorn Amnuayphonwiwat, Pharm.D., a pharmacist from the Outpatient Pharmaceutical Care Unit, Outpatient Pharmacy Division, Pharmacy Department, Siriraj Hospital, Mahidol University, participated in the “FAPA 2024 Congress” in Seoul, Republic of Korea, between October 29th – November 2nd, 2024. She presented a poster titled “Efficacy and Safety of Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i) in Patient with Heart Failure with Reduced Ejection Fraction in Heart Failure Clinic Tertiary-care Hospital in Thailand by Multidisciplinary Care Team”. Pharmacist Amnuayphonwiwat aims to enhance patient care and gain insights to further develop her skills.
Under the theme “Next Generation Pharmacists in Asia: Pharmacists Integrated Role to Enhance Care and Pharmaceutical Sciences”, the FAPA 2024 Congress serves as a vital platform for Asian pharmacists to discuss rapidly evolving areas such as digital health, artificial intelligence, and precision medicine. The event aims to equip pharmacists with insights to adapt to future shifts in the pharmaceutical and healthcare landscape.
